INDICATOR cohort "proactive" criteria[1] | INDICATOR cohort "conservative" criteria[1] | 2018 American Heart Association/ American College of Cardiology adult CHD guidelines[2] | 2020 European Society of Cardiology adult CHD guidelines[3] | 2022 Canadian Cardiovascular Society adult CHD guidelines[4] |
PR regurgitant fraction >25%, plus ≥2 of the following: - RVEDVi >160 mL/m2
- RVESVi >80 mL/m2
- RVEF <47%
- LVEF <55%
- QRS duration >160 ms
| PR regurgitant fraction >25%, plus ≥2 of the following: - RVEDVi >180 mL/m2
- RVESVi >95 mL/m2
- RVEF <40%
- LVEF <45%
- QRS duration >180 ms
| Moderate or greater PR, plus: - Cardiovascular symptoms not otherwise explained, or
- ≥2 of the following:
- RVEDVi ≥160 mL/m2
- RVEDV ≥2× LVEDV
- RVESVi ≥80 mL/m2
- Mild or moderate RV or LV systolic dysfunction
- Objectively reduced exercise capacity
- Significant RVOTO (RVp ≥2/3 systemic pressure)
- Ventricular tachyarrhythmia
| Severe PR, plus ≥1 of the following: - Cardiovascular symptoms not otherwise explained
- RVEDVi ≥160 mL/m2
- RVESVi ≥80 mL/m2
- Moderate or greater TR
- Progressive RV systolic dysfunction
- Objectively reduced exercise capacity
- Significant RVOTO (RVp >80 mmHg)
| Severe PR (regurgitant fraction >25% on CMR or qualitatively severe by echocardiography), plus ≥1 of the following: - Cardiovascular symptoms not otherwise explained
- RVEDVi ≥160 mL/m2
- RVESVi ≥80 mL/m2
- RV systolic dysfunction
- Objectively reduced exercise capacity
- Significant RVOTO (RVp ≥2/3 systemic pressure)
- Sustained ventricular tachyarrhythmia
|